Latest Regulatory News

Bass Oil Limited reported a 3% rise in September oil production, driven by a 20% uplift in Indonesian output, while awaiting regulatory approval for a strategic gas field acquisition.

Imagion Biosystems has made significant strides toward filing an IND application for its MagSense® HER2 breast cancer imaging agent, supported by positive FDA feedback and a recent $3.5 million capital raise to fund upcoming clinical trials.

Pilot Energy has secured crucial environmental approval to conduct a 3D seismic survey offshore Perth Basin, propelling its exploration and farmout ambitions forward while supporting carbon storage initiatives.

Moho Resources has raised $2 million through a share placement to fund an extensive drilling and sampling campaign at its Bush Chook Project, aiming to validate historical gold anomalies and expand its resource base.

Mayne Pharma has announced the rescheduling of its Supreme Court hearing to November 3, 2025, to approve the acquisition scheme by Cosette Australia BidCo, pending Foreign Investment Review Board approval.

VHM Limited has obtained conditional financial backing of up to A$379 million from Export Finance Australia and the US Export-Import Bank to advance its Goschen Rare Earths and Mineral Sands Project in Victoria.

BPH Global Ltd reports a steady increase in Indonesian seaweed sales alongside securing a crucial export licence, setting the stage for international market entry.

Findi Limited has arranged a new A$30 million debt facility and agreed to acquire Sphere, enhancing its digital payments ecosystem ahead of a planned FY27 Indian IPO. Despite short-term challenges, the company projects strong revenue growth and operational momentum in FY26.

Freehill Mining reports strong magnetite concentrate grades at its Yerbas Buenas project, while advancing its aggregates business and exploring copper-gold opportunities in Chile.

PYC Therapeutics has kicked off a global Phase 1b repeat dose study of its investigational drug PYC-001 targeting Autosomal Dominant Optic Atrophy, a rare genetic eye disease with no current treatments. Initial dosing has begun, with key data expected in the second half of 2026.

Resouro Strategic Metals has raised CAD$1 million through the first tranche of a private placement, advancing its Tiros Titanium-Rare Earths Project in Brazil. The company plans to use the funds to progress engineering work ahead of a Preliminary Economic Assessment.

Nexsen Limited has initiated clinical trials for its StrepSure® GBS Rapid Sensor, a next-generation diagnostic device aimed at improving maternal health outcomes. The trial's success could pave the way for regulatory approval and early market penetration by the second half of 2026.